Treatment of gastrointestinal disease with ppar modulators

Methods and compositions are provided for treating a host having a gastrointestinal (GI) disease by administering to the host a composition containing a pharmaceutically effective amount of a modulator of a Peroxisome Proliferator Activated Receptor (PPAR), particularly a modulator of PPAR gamma . Screening methods are also provided for identifying PPAR modulators which utilize cells derived from gastrointestinal tissue which express PPARs


    Applicant(s): Ligand Pharm Inc [Us], Pasteur Institut [Fr], Lefebvre Anne-Marie, Auwerx Johan, Briggs Michael R


    Record created on 2009-04-21, modified on 2017-05-12


  • There is no available fulltext. Please contact the lab or the authors.

Related material